BioRay Pharmaceutical Co., Ltd.
Registry sponsor category
Industry
- Other names
- BioRay Pharmaceutical Co., Ltd.
- Company name
- BioRay Pharmaceutical Co., Ltd.
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (17)
- A Clinical Study to Evaluate Single-agent Therapy of BR113 for Injection in Patients With Advanced Solid Tumors
- A Phase I Study of BR108 in Hematological Malignancies
- A Phase I Study of BR115 for Injection Alone in Subjects With Advanced Solid Malignancies
- A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous Nephropathy
- A Study of BR101 Injection Alone in Subjects With Advanced Solid Tumors
- A Study of BR111 in Patients With Advanced Malignancies
- A Study of BRY805 in Participants With Advanced Solid Tumors
- A Study of BRY812 for Injection Alone in Subjects With Advanced Malignancies
- Clinical Study of BR105 Injection
- Clinical Trial of BR2251 Tablets for Patients With Primary Gout and Hyperuricemia
- Comparison of Pharmacokinetics and Safety of HS627(2 Specifications) Versus PERJETA With a Single Injection
- Comparison of Pharmacokinetics and Safety of HS632 and Xolair® With a Single Injection
- Phase I Randomized, Open-label, Parallel-controlled, Pharmacokinetic and Safety Study of BR201 Injection Versus Cosentyx in Healthy Male Subjects
- Phase I/II Clinical Study of 1A46 Drug Substance
- Phase IIa Study of BRY812 Monotherapy in Advanced Gynecological Malignancies
- Treatment of Breast Cancer With Trastuzumab + HS627/ Pertuzumab + Docetaxel
- Treatment of Orelabrutinib+Hi-CVP Regimen for Previously Untreated MZL